Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Nov;90(2):256–259. doi: 10.1111/j.1365-2249.1992.tb07938.x

IgA rheumatoid factor in mucosal fluids and serum of patients with rheumatoid arthritis: immunological aspects and clinical significance.

H G Otten 1, M R Daha 1, M G van der Maarl 1, L I Hoogendoorn 1, E M Beem 1, H H de Rooy 1, F C Breedveld 1
PMCID: PMC1554607  PMID: 1424283

Abstract

In order to gain insight into the production and clinical significance of IgA rheumatoid factor (IgA-RF) in mucosal fluids of patients with rheumatoid arthritis (RA), we examined tear fluid, saliva and serum from 80 patients with RA. Significant correlations were found between IgA-RF levels in tear fluid and saliva (P = 0.002, r = 0.57), saliva and serum (P < 0.001, r = 0.79), and serum and tear fluid (P < 0.001, r = 0.31). No significant correlations were found between total IgA levels in these fluids. Comparison between circulating and mucosal IgA-RF levels after correction for total IgA, revealed that mucosal IgA-RF levels are on average 2.5 times higher than circulating IgA-RF levels. Analysis of IgA-RF specificity showed that lacrimal and salivary IgA-RF reactivity with various IgG subclasses is similar and differs from serum IgA-RF specificity. These results indicate local production of IgA-RF in salivary and lacrimal glands and support the view of a common origin of IgA-RF producing B cells present in mucosal tissues. Mucosal and circulating levels of IgA and IgA-RF were not associated with tests that quantify tear fluid production. This indicates that mucosal and circulating levels of IgA and IgA-RF in patients with RA cannot be regarded as markers for the development of secondary Sjögren's syndrome.

Full text

PDF
256

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnason J. A., Jónsson T., Brekkan A., Sigurjónsson K., Valdimarsson H. Relation between bone erosions and rheumatoid factor isotypes. Ann Rheum Dis. 1987 May;46(5):380–384. doi: 10.1136/ard.46.5.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  3. Craig S. W., Cebra J. J. Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit. J Exp Med. 1971 Jul 1;134(1):188–200. doi: 10.1084/jem.134.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dunne J. V., Carson D. A., Spiegelberg H. L., Alspaugh M. A., Vaughan J. H. IgA rheumatoid factor in the sera and saliva of patients with rheumatoid arthritis and Sjögren's syndrome. Ann Rheum Dis. 1979 Apr;38(2):161–165. doi: 10.1136/ard.38.2.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eggelmeijer F., Otten H. G., de Rooy H. H., Daha M. R., Breedveld F. C. Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis. Rheumatol Int. 1990;10(1):43–46. doi: 10.1007/BF02274780. [DOI] [PubMed] [Google Scholar]
  6. Elkon K. B., Gharavi A. E., Patel B. M., Hughes G. R., Frankel A. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Clin Exp Immunol. 1983 Apr;52(1):75–84. [PMC free article] [PubMed] [Google Scholar]
  7. Kagnoff M. F. Functional characteristics of Peyer's patch cells. III. Carrier priming of T cells by antigen feeding. J Exp Med. 1975 Dec 1;142(6):1425–1435. doi: 10.1084/jem.142.6.1425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koopman W. J., Schrohenloher R. E., Crago S. S., Spalding D. M., Mestecky J. IgA rheumatoid factor synthesis by dissociated synovial cells. Characterization and relationship to IgM rheumatoid factor synthesis. Arthritis Rheum. 1985 Nov;28(11):1219–1227. doi: 10.1002/art.1780281105. [DOI] [PubMed] [Google Scholar]
  9. Mestecky J., McGhee J. R. Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol. 1987;40:153–245. doi: 10.1016/s0065-2776(08)60240-0. [DOI] [PubMed] [Google Scholar]
  10. Mestecky J., Russell M. W., Jackson S., Brown T. A. The human IgA system: a reassessment. Clin Immunol Immunopathol. 1986 Jul;40(1):105–114. doi: 10.1016/0090-1229(86)90073-5. [DOI] [PubMed] [Google Scholar]
  11. Otten H. G., Daha M. R., de Rooij H. H., Breedveld F. C. Quantitative detection of class-specific rheumatoid factors using mouse monoclonal antibodies and the biotin/streptavidin enhancement system. Br J Rheumatol. 1989 Aug;28(4):310–316. doi: 10.1093/rheumatology/28.4.310. [DOI] [PubMed] [Google Scholar]
  12. Ottèn H. G., Daha M. R., van Laar J. M., de Rooy H. H., Breedveld F. C. Subclass distribution and size of human IgA rheumatoid factor at mucosal and nonmucosal sites. Arthritis Rheum. 1991 Jul;34(7):831–839. doi: 10.1002/art.1780340708. [DOI] [PubMed] [Google Scholar]
  13. Schrohenloher R. E., Koopman W. J., Alarcón G. S. Molecular forms of IgA rheumatoid factor in serum and synovial fluid of patients with rheumatoid arthritis. Arthritis Rheum. 1986 Oct;29(10):1194–1202. doi: 10.1002/art.1780291003. [DOI] [PubMed] [Google Scholar]
  14. Teitsson I. IgA rheumatoid factor as predictor of disease activity. Scand J Rheumatol Suppl. 1988;75:233–237. doi: 10.3109/03009748809096769. [DOI] [PubMed] [Google Scholar]
  15. Van Snick J. L. The production of anti-IgG2a autoantibody in the 129/Sv mouse: onset in the lymph nodes draining the intestinal tract and prevention by neonatal thymectomy. J Immunol. 1981 Mar;126(3):815–818. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES